All trans retinoic acid and vitamin D3 derivatives are well known for their antileukemic activity, while the precise mechanism of this effect remains to be clarified. Using human leukemic U937 and THP-1 promonocytic cell lines, we analyzed the effect of all-trans retinoic acid (RA) and/or 1.25-dihydroxyvitamin D3 (VD) on the generation of nitric oxide (NO), a potent antitumoral mediator. U937 cell differentiation with VD or with both RA and VD (RA/VD) correlated with gene transcription and functional expression of inducible nitric oxide synthase (iNOS). Nitrites and L-citrulline were also detected in U937 cell supernatants as soon as 24 hours following cell incubation with VD or RAND, but not ITRIC OXIDE (NO) is generated from the oxidation N of the terminal guanido nitrogen atom(s) of L-arginine by an nicotinamide adenine dinucleotide phosphate (NADPH)-dependent enzyme, the NO-synthase (NOS). NO from activated macrophages is an important cytostatic or cytotoxic mediator for tumor cells and a variety of pathogens, including infective fungal, helminth, bacterial, and protozoan THP-I and U937 leukemia cells were plated at a final cell concentration of 2 x 10' cellslml in Iscove medium that initially contained I mmol/L of L-arginine and was supplemented with 100 UlmL penicillin, 100 pglmL streptomycin, 5% fetal calf serum (FCS) and incubated for 4 days at 37°C under 5% C 0 2 and humid atmosphere in the presence or absence of 0.1 pmollL RA and/or 0. I pmol/L VD; these concentrations being already described as optimal in this ~y s t e m . '~ Culture media were shown to be endotoxin-free as assessed by the limulus amoebocyte lysate assay (Sigma). Cell viability was assessed by trypan blue exclusion staining after each culture period.
asked whether the role of the L-arginine/NO pathway in RA/ VD-induced differentiation of promonocytic U937 and THP-1 leukemic cells, and its potential role in the antitumoral effect was evaluated. Our data demonstrate the ability of VD or R A N D to promote the expression of functional inducible nitric oxide synthase (iNOS) in U937 and THP-1 cells. This phenomenon seems to be essential in the antileukemic effects of these treatments.
MATERIALS AND METHODS
All trans retinoic acid (RA), L-and D-arginine, EGTA, and N"-monomethyl-L-arginine (LNMMA) were purchased from Sigma (St Louis, MO). 1,25-Dihydroxy-vitamin D? (VD) was kindly provided by Dr D. Lando (Roussel-Uclaf, Romainville, France). The I4C labeled L-arginine was purchased from Amersham (Amersham, Les Ulis, France). The strong acid cation exchange resin, binding to L-arginine but not to L-citrulline (AG 50W-X8), was purchased from Biorad Laboratories (Richmond, CA).
THP-I and U937 leukemia cells were plated at a final cell concentration of 2 x 10' cellslml in Iscove medium that initially contained I mmol/L of L-arginine and was supplemented with 100 UlmL penicillin, 100 pglmL streptomycin, 5% fetal calf serum (FCS) and incubated for 4 days at 37°C under 5% C 0 2 and humid atmosphere in the presence or absence of 0.1 pmollL RA and/or 0. I pmol/L VD; these concentrations being already described as optimal in this ~y s t e m . '~ Culture media were shown to be endotoxin-free as assessed by the limulus amoebocyte lysate assay (Sigma). Cell viability was assessed by trypan blue exclusion staining after each culture period.
Immunochemical staining. Surface markers were analyzed by indirect immunoperoxidase methods (Vector Laboratories, Burlingame, CA). For iNOS, the cells were permeabilized by paraformaldehyde (3%) and then treated with H20z (0.3%) to block endogenous peroxidases before labelling with rabbit antimouse iNOS antiserum" or rabbit preimmune serum. The anti-CD14 and the anti-CD68 monoclonal antibodies (MoAbs) were obtained from Dako (Les Ulis, France) and were used for phenotypical analysis by immunostaining.
U937 cells treated or not with
RA and/or VD were lysed in 10 mmol/L Tris-HCI, pH 7.4 buffer heated to 90°C. The buffer contained I % of sodium dodecyl sulfate (SDS), 10 pg/mL leupeptin, 2 mmol/L phenylmethylsulfonyl fluoride (PMSF), 2 pg/mL aprotinin, 10 pglmL pepstatin A, and 2 m o l l L phenanthroline. The lysate was then sonicated briefly to decrease viscosity. Samples of 40 pg were electrophoresed under reducing conditions on 7.5% SDS-polyacrylamide minigels. Proteins were Reagents.
Cell culture.
Western blot analysis fbr iNOS. For personal use only. on October 22, 2017. by guest www.bloodjournal.org From then electroblotted to 0.2 pm vinylidene difluoride and the membrane blocked with 10 mmolfL Tris-HCI, 100 mmol/L NaCI, pH 7.5 (TBS) containing 1% bovine serum albumin and 0.1% Tween 20. Blots were then incubated with the rabbit antimouse iNOS antiserum or rabbit preimmune serum at a final concentration of 1/500 VOUVOI.'~ The blots were then washed with TBS, 0.1% Tween 20 and incubated with a goat antirabbit Ig conjugated to horseradish peroxidase and bands were revealed by luminol-dependent chemiluminescence. The maximum light emission is at a wavelength of 428 nm and was detected by short exposure to blue light sensitive autoradiography film (Hyperfilm ECL, Paris, France).
Analysis of iNOS gene expression. Inducible NO-synthase mRNA expression was investigated with reverse transcriptase-polymerase chain reaction (RT-PCR) as described.' Indeed, as already shown for most of the hematopoietic cells, the expression of iNOS mRNA was low and did not allow its detection by classical Northern blot analysis. The sequences of the oligonucleotide primer sets in these experiments were as follows: iNOS mRNA sense (5' TCC-GAGGCAAACAGCACA'ITCA 3') and iNOS mRNA antisense (5' GGGTTGGGGGTGTGGTGATGT 3' ). Hypoxanthine phosphoribosyl transferase (HPRT) mRNA sense (5' TATGGACAGGAC-TGAACGTC'ITGC 3') and HPRT mRNA antisense (5' GACACA-AACATGA'ITCAAATCCCTGA 3'). The iNOS message is represented by a 371-bp band, and a 496-bp band indicates the HPRT message.
PCR amplification was also analyzed by Southern blot. Hybridization was performed in Church solution with the hepatic iNOS cDNA (iNOS Hep clone 3D, 2.1-kb fragment from base 1757 to 3119), which was kindly provided by Dr A. Niissler (Ulm, Germany). The probe was labelled for Southern blot analysis with [a3'P]-dCTP using the Megaprime DNA labelling kit (Amersham). Filters were then washed at a final stringency of 0.1 X SSC at 65°C and autoradiographed after ultraviolet (UV) illumination with FUJI RX-L films (Paris, France) for 1 to 3 hours.
I4C L-arginine incorporation was evaluated as previously described? Briefly, 10 million cells per condition were lysed by four cycles of freezing in liquid nitrogen and thawing in a buffer containing protease inhibitors: leupeptin 1 pg/mL, pepstatin 1 pg/mL, bestatin 40 pg/mL, chymostatin IO pg/mL, aLTosyl-choromethyl-ketone (TLCK) 50 pg/mL, and 4-(2-Aminoethy1)benzenesulfonylfluoride (AEBSF) 1 mmol/L and 5 mmol/L dithiothreitol (Sigma). They were then centrifuged at 20,OOOg for 1 hour at 4°C. Twenty microliters of the supernatant (the cytosol) was then incubated for 15 minutes at 37°C with KH,PO, 50 mmol/L,
and cold L-arginine 20 pmol/L. The reaction was stopped with the resin suspension, and after strong mixing the supernatants were removed into scintillation vials. The reaction was performed with or without EGTA (1 mmol/L) to determine the calcium-independent activity of the inducible enzyme. An inhibitor of the NO-synthase enzyme (LNMMA, 1 mmol/L) was also used in each condition to determine the background count.
To assess the amount of NO produced, the culture supernatants were assayed for accumulation in the supernates of the stable end product of NO, NO; measured using the Griess reaction and by L-citrulline production as previously described.I6 Briefly, L-citrulline was measured by the colorimetric reaction of carbamido groups with diacetyl monoxime in acid solution." A total of 30 pL of urease (25 U h L ) was added to 300 pL of supernatants for a 1-hour incubation at 37°C. After addition of 37.5 pL of TCA (59% voYvol), the precipitated proteins were removed by a 5-minute centrifugation at 11,OOO rpm in an Eppendorf centrifuge. A total of 250 pL of supernatants was harvested, and 300 pL of a 1: 1 (voYvol) mixture of 240 mmolR. diacetyl monoxime
Enzymatic iNOS activity.
NO; and L-citrulline measurements. and a solution of phenazone (3 g in 10.1 mL H20 reacted with 12 mg FeS04 and 21 mL H2S04 36N) was added for a 15-minute incubation at 90°C in the dark. A total of 200 pL was collected and transferred to a microtitration plate for measurement of the optical density (OD) at 492 nm using an autoreader (Dynatech Laboratories Inc, Boulogne, Billancourt, France). A calibration curve was performed in parallel with a standard solution of citrulline.
Luminol-dependent chemiluminescence (LDCL). To measure cellular respiratory burst activity, LDCL was monitored over a fixed period in a luminometer (Lumicon, Hamliton, Switzerland) as previously des~ribed.'~ Briefly, 5 X IO5 cells in 500 pL RPMl medium without phenol red were transferred in a counting tube filled with 500 pL luminol (6 X mmol/L in phosphate-buffered saline [PBS]). The suspension was prewarmed at 3 7 T , before a 50-pL addition of 1 mg/mL of zymosan opsonized with human serum (Zy ops). Light emission was then measured for 1 minute with 5-minute intervals during 30 minutes.
Statistics. Statistical analyses were done according to the Student's t-test.
RESULTS
Synergistic effect of RA and VD in inhibiting cell growth and inducing differentiation of U937 cells. To confirm the sensitivity of U937 cells to RA, VD, or both, we have incubated these cells in the presence of these factors. As already de~cribed,'~ these experiments show that cell treatment with VD alone induced, after 4 days in culture, a significant inhibition ( P < .01) of cell growth (Fig 1A) . VD-treated cells also had an increased expression of CD14 and CD68 mature cell markers (Fig IB) , as well as respiratory burst capacity, as observed by the opsonized zymosan-induced LDCL ( Fig  IC) . In contrast, RA only reduced cell growth without affecting differentiation marker expression and LDCL capacity of these cells. However, when RA was added to VD, surface expression levels of CD14 and CD68 and intracellular respiratory burst significantly increased, which pointed to a synergistic effect ( P < .01) of these two factors in inducing U937 cell differentiation. Other cell markers associated with the differentiation of promonocytes into monocytic cells such as CD1 l b are also induced by VD and RAND, whereas the CD33 marker was decreased (data not shown). As for U937 cells, using another promocytic cell line THP-1, RA, inefficient alone, synergized with VD in inducing growth arrest and their differentiation into monocytic cells as shown by the induction of CD14 and by the increased capacity to produce LDCL in response to Zy ops (Table 1) .
RA synergizes VD in inducing iNOS expression and activity by leukemic cells. To assess the role of NO in antileukemic effects of RAND, the expression of iNOS was first analyzed in U937 cells before and after treatment with RA andor VD. Figure 2 shows that treatment of U937 cells with VD induces a detectable level of iNOS mRNA as evidenced by RT-PCR. Addition of RA to VD further increased the mRNA expression, which correlated with their synergistic effect in cell differentiation. Southern blot analysis of RT-PCR products with a specific human iNOS probe further confirmed the induction of iNOS mRNA transcription in these culture conditions. Cloning and sequencing of the PCR products indicated iNOS expressed in VD-and RANDtreated cells was 100% identical to the hepatocyte iNOS. The expression of iNOS was also investigated at the protein level using anti-iNOS antisera. As shown in Fig 3, cells treated with RAND (Fig 3D) show higher immune reactivity in their cytoplasm than cells treated with VD (Fig 3B) alone, whereas control (Fig 3A) and RA-treated ones (Fig 3C) were negative. Specific Western blotting for iNOS clearly showed the expression of a major 135 kD for VD-and RANDtreated cells (Fig 4) , whereas it was not observed in control DUGAS ET AL and in RA-treated cells. Following the demonstration of iNOS mRNA and protein, we asked whether iNOS expression is functional through the ability of cellular extracts to convert ''C L-arginine into ''C L-citrulline. Results in Table  2 show that treatment with VD induces iNOS activity, potentiated through simultaneous addition of RA. This effect is L-arginine-dependent, as it could be reversed through the addition of LNMMA during this assay. Chelation of Ca2+
by EGTA did not significantly reduce enzymatic activity (P < .Ol) correlating with actual iNOS definition. Meanwhile, the residual NOS activity observed in untreated or in RAtreated U937 cells was sensitive to both LNMMA and EGTA, suggesting the existence of a constitutive calciumdependent NOS in U937 cells" ( Table 2 ). In addition to iNOS activity, we have quantified the concentrations of nitrite and L-citrulline end products of NOS pathway in supernatants from U937 cells following 4 days' incubation in the presence or absence of RA and/or VD. Significant levels of nitrite and of L-citrulline (P < culture medium of RAND-treated cells (Table 3) 5 and 6) . and cells were lysed and thecell lysate analyzed by Western blot with a polyclonal rabbit antirat iNOS that cross reacts with the human one, as described in Materials and Methods. As a control, the preimmune serum did precipitate the 135-kD specific band for iNOS. suppressed by LNMMA and reverted in the presence of an excess of L-arginine, but not of D-arginine, indicating that NO was involved in this process (Fig 5) , the effect of RA not being modified. Similarly, the induction of CD14 and CD68 (Fig 6A) , as well as zy ops-induced LDCL (Fig 6B) in VD-and RAND-treated cells, was decreased by the treatment with LNMMA. Data obtained with THP-I cells indicated that, in contrast to U937 cells, LNMMA treatment did not fully suppress the RAND-induced CD14 and CD68 expression, as well as LDCL activity suggesting the requirement for other intracellular biochemical pathways during THP-I cell differentiation. To further confirm the role of NO in promonocytic cell differentiation,"." we have treated the cells with a chemical donor of NO, sodium nitroprusside (SNP) ( Table 4) , and it was found that compared with RA/ VD treatment, SNP induced comparable expression of CD 14 and CD68, as well as LDCL response to opsonized zymozan, strengthening the idea that NO is an important component for monocytic differentiation in vitro.
DISCUSSION
In the present study, we report the role of NO on the growth and differentiation of promonocytic leukemic cells treated with VD or with RAND. Differentiation of the human promonocytic cell lines U937 and THP-1 by VD or the combination of RA and VD induced functional iNOS gene expression in these cells. NO generation by VD-and RA/ VD-treated cells was required for the antitumoral effect of these compounds because a competitive inhibitor of the Larginine/NO pathway, LNMMA, significantly decreased the growth arrest and the subsequent differentiation of leukemic cells. These data fit and extend data from other laboratories indicating that chemical donors of NO induced the differentiation of promonocytic leukemia cells.'"'' This effect of NO is apparently in contradiction with another report.'* In fact, this work indicated that early alteration of L-arginine metabolism could be important for the intiation or the enhancement of the cytokine-induced differentiation, and in our system using the R A N D treatment, we clearly indicated that NO could play an important role in the final differentiation of these cells and appears not to be essential in the initial steps of maturation because functional iNOS detection was observed only 3 to 4 days after the beginning of the treatment with RAND. In addition, in Fig 5, it was shown that LNMMA fully suppress the induction of CD14 and CD68, as well as LDCL activity in U937 cells, but not in THP-1 cells, suggesting that in the latter cell line, with a more mature stage of differentiation than U937, signaling events other than NO are required to obtain full differentiation. Although, taken together, if these data suggest that NO acts as a differentiating regulatory molecule all along the monocyte/macrophage lineage, they also suggest that NO exerts its differentiating effect at precise and yet undefined stages of differentiation.
It is now established that iNOS expression can be obtained in a reproducible manner in human macrophages after ligation of the C-lectin family markers such as CD23" and For personal use only. on October 22, 2017. by guest www.bloodjournal.org From CD69'" or after stimulation of the cells by the human immunodeficiency virus." This work demonstrates unambiguously that iNOS mRNA can be pharmacologically induced in human monocytic cells and constitutes a potent model for iNOS investigation. The molecular basis of the VD-and RAI VD-induced iNOS expression in human leukemic cells is presently unknown. VD was previously shown to induce the production of tumor necrosis factor-a (TNF-0) by human promonocytic cell lines.I4 In addition to the antitumoral ef- fect of TNF-a, this cytokine is required to obtain optimal iNOS transcription and NO generation by human macrophages (F. Ouaaz et al, manuscript in preparation). Treatment of U937 cells with VD or RAND also induced the expression of CD23 activation antigen on the surface of leukemic cells. This antigen was recently shown to mediate early hematopoietic cell differentiation towards monocytic lineage, in part through its ability to induce NO pathway." In fact, ligation of CD23, which can be achieved by neighboring cells expressing CDI 1 blc,*' promotes the transcription of the iNOS gene and consequent generation of iNOS protein and enzymatic activity. The ability of RA to potentiate a VD effect may be due to some essential metabolic enzyme for 1,25-dihydroxyvitamin D3. The fact that RA synergizes with VD in inducing iNOS led us to suspect that the intracellular pathway required to obtain optimal expression of iNOS in promonocytic cells is common in both products. RA and VD exert most of their biological actions through nuclear signaling pathways and receptors that belong to the same family of ligand-inducible transcriptional activators and are expressed in most leukemic cell lines, including U937 and THP-1 cells.*'.'' This study shows the role of functional iNOS expression in the antitumoral effect of VD or RAND. NO is well known as an important antitumoral mediator of human macrophages For personal use only. on October 22, 2017. by guest www.bloodjournal.org From through the activation of hem-oxygenase enzyme, the soluble guanylate cyclase leading to cyclic guanosine monophosphate (cGMP) and cyclic adenosine monophosphate (CAMP) generation,'." well known to elicit antitumoral a~tivity.~'~'' Recently, NO was also shown to be involved in the inhibition of the proliferation and the apoptosis of early human CD34+ precursor cells following their in vitro treatment with TNFa and interferon (IFN)-Y.~ NO may mediate an antitumoral effect through its ability to induce TNF-a expression by various hematopoietic cells, including monocyte/macrophage lineages. The addition of chemical NO donors to human acute myelogenous leukemia cells or murine monocytic J774A1 cells resulted in their growth inhibition and the expression of differentiation-related oncogenes by these cells.** NO donors may thus be of potential antitumoral therapy or adjuvant therapy in myeloid leukemia patients.
